Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
KLRS
$2.05
+0.00%
KLRS
· Kalaris Therapeutics, Inc.
Market Cap
$48.80M
Shares
23.80M
Volume · Nov 4
28.26K
Avg daily vol (3M)
64.89K
All webcasts
Earnings call · FY2022 Q3
Kalaris Therapeutics, Inc. (KLRS) Q3 2022 Earnings Call
Diluted EPS
-$11.50
Net income
-$42.07M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 3, 2022 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 3, 2022 · complete as-filed document